An open-label dosing study of paroxetine in depressed children and adolescents-Reference-Cited by-同舟云学术

An open-label dosing study of paroxetine in depressed children and adolescents

Published:2002-09 Issue:9 Volume:63 Page:588-601
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Findling Robert L.,Myers Carolyn,O'Riordan Mary Ann,Branicky Lisa A.,Pettigrew Anita,Reed Michael D.,Blumer Jeffrey L.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. Childhood and adolescent depression: A review of the past 10 years;Birmaher;J Am Acad Child Adolesc Psychiatry,1996

2. Pharmacological treatment of depression in children and adolescents;Findling;Paediatr Drugs,1999

3. Paroxetine: An overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression;Nemeroff;J Clin Psychopharmacol,1993

4. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders;Gunasekara;Drugs,1998

5. Optimal dose regimen for paroxetine;Dunner;J Clin Psychiatry,1992

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pilot Pharmacotherapy Trial for Depressed Youths at High Genetic Risk for Bipolarity;Journal of Child and Adolescent Psychopharmacology;2008-12

2. Venlafaxine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder;Journal of Child and Adolescent Psychopharmacology;2007-08

3. The Relevance of Pharmacokinetic Studies in Designing Efficacy Trials in Juvenile Major Depression;Journal of Child and Adolescent Psychopharmacology;2006-03

4. A Cumulative Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Pediatric Depression: Did Unpublished Studies Influence the Efficacy/Safety Debate?;Journal of Child and Adolescent Psychopharmacology;2006-03

5. Multiple Dose Pharmacokinetics of Paroxetine in Children and Adolescents with Major Depressive Disorder or Obsessive–Compulsive Disorder;Neuropsychopharmacology;2005-11-23